LPK-26
From Wikipedia, the free encyclopedia
Systematic (IUPAC) name | |
---|---|
2-(3,4-dichlorophenyl)-N-[(2S)-1-(2,5-dihydropyrrol-1-yl)-3-methylbutan-2-yl]-N-methylacetamide | |
Clinical data | |
Legal status | ? |
Identifiers | |
CAS number | 492451-07-7 |
ATC code | ? |
PubChem | CID 10043746 |
Chemical data | |
Formula | C18H24Cl2N2O |
Mol. mass | 355.301 g/mol |
SMILES
| |
(what is this?) (verify) | |
LPK-26 is a drug which acts as a potent and selective κ-opioid agonist, and has analgesic effects.[1]
References
- ↑ Tao YM, Li QL, Zhang CF, Xu XJ, Chen J, Ju YW, Chi ZQ, Long YQ, Liu JG (April 2008). "LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential". European Journal of Pharmacology 584 (2-3): 306–11. doi:10.1016/j.ejphar.2008.02.028. PMID 18353307.
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.